Interstitial Lung Disease
Conditions
Keywords
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Electronic Health Records, Computed Tomography, Mortality, Hospitalization, Acute care visits, Anti-inflammatory drug therapies
Brief summary
The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Interstitial Lung Disease (ILD) ICD-9 code diagnosis 515.0 or 516.3
Exclusion criteria
* Inadequate documentation of patient receiving care for ILD in the health records
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Population | up to 5 years |
| Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Population | up to 5 years |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Disease | up to five years | Compare the prevalence of diabetes with interstitial lung disease as compared to the prevalence of diabetes in the general VA population |
| Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Disease | up to 5 years | Will compare the reported ICD-9 code diagnosis with the diagnosis made after chart review and re-interpretation of the lung imaging and pathology |
| Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary provider | up to 5 years | — |
Countries
United States